About StromaGenesis Informing Precise Therapy


StromaGenesis, LLC, founded in 2022 by Dr. Richard Pestell, is a clinical‑stage biotech company advancing precision oncology by targeting the tumor microenvironment. It has developed a proprietary prostate cancer prognostic algorithm and tissue‑ and blood‑based immunoassays that predict therapy response and act as companion diagnostics for solid tumors such as breast, colon, prostate, and glioblastoma.

The platform offers investors a scalable, de‑risked approach with multiple near‑to‑mid‑term opportunities in the growing precision‑medicine market.

For more details, visit here: www.stromagenesis.com

Comments

Post a Comment

Popular posts from this blog

The Power of Purpose: Combining Medicine, Leadership, and Social Change for a Healthier Tomorrow

Medicine has always been a profession centered on helping people live healthier lives. While diagnosing illnesses and providing treatment remain essential responsibilities, healthcare professionals are now expected to take on much broader roles. They influence healthcare systems, guide medical teams, educate communities, and support positive social change. Balancing medicine, leadership, and social impact creates opportunities to improve lives at both the individual and community levels. The healthcare field continues to evolve as technology advances, patient needs become more complex, and communities face new public health challenges. Medical professionals who embrace leadership and community involvement are better prepared to make a meaningful difference. Their ability to combine clinical expertise with strong leadership skills allows them to deliver better care while creating lasting improvements in society. Medicine Goes Beyond Treating Illness The role of healthcare professionals...
Read more

Beyond the Clinic: Why Every Oncology Specialist Should Embrace Philanthropy

Cancer care has evolved dramatically over the last few decades. With advances in precision medicine, immunotherapy, and early detection, oncology specialists now play a central role not only in treatment but also in long-term survivorship and quality-of-life planning. Their influence extends beyond hospital walls into communities, research institutions, and policy discussions that shape the future of care. As the responsibilities of oncology specialists expand, so does their potential to make an impact beyond traditional clinical duties. Philanthropy offers a meaningful avenue for these professionals to address systemic gaps, fund innovation, and improve access to care. By engaging in charitable initiatives, oncology specialists can amplify their expertise and drive broader-scale change that benefits patients. Strengthening Access to Care Many cancer patients face significant barriers to treatment, including financial hardship, transportation challenges, and limited access to speciali...
Read more

The Impact of Physician Leadership on Healthcare Growth and Excellence

Physicians have a unique opportunity to influence healthcare organizations through strong leadership and strategic thinking. Their clinical experience gives them valuable insight into patient needs, team challenges, and operational improvements. Today, physician leadership development helps medical professionals expand their impact beyond direct care and contribute to organizational success. Effective physician leaders create stronger teams, improve communication, and encourage innovation throughout healthcare systems. Furthermore, they understand that successful organizations require collaboration between clinical expertise and administrative strategies. By embracing leadership responsibilities, physicians can guide meaningful changes that improve performance, strengthen trust, and support better outcomes for patients and communities. Creating Direction Through Purposeful Physician Leadership Physician leaders help organizations succeed by establishing clear goals that connect health...
Read more